Results
1 -
8 of
8
(Click
here to explore results)
- Chemogenomics for drug discovery: clinical molecules from open access chemical probes. Robert B. A. Quinlan, Paul E. Brennan
, RSC Chem. Biol.
, 2021
, 2
, 759
- Effect of small molecules on cell reprogramming. M. Baranek, A. Belter, M. Z. Naskręt-Barciszewska, M. Stobiecki, W. T. Markiewicz, J. Barciszewski
, Mol. BioSyst.
, 2017
, 13
, 277
- Development of second generation epigenetic agents. Philip Jones
, Med. Chem. Commun.
, 2012
, 3
, 135
- Synthesis and evaluation of protein arginine N-methyltransferase inhibitors designed to simultaneously occupy both substrate binding sites. Matthijs van Haren, Linda Quarles van Ufford, Ed E. Moret, Nathaniel I. Martin
, Org. Biomol. Chem.
, 2015
, 13
, 549
- Histone demethylating agents as potential S-adenosyl-l-methionine-competitors. R. Navakauskienė, M. Mori, M. S. Christodoulou, A. Zentelytė, B. Botta, L. Dalla Via, F. Ricci, G. Damia, D. Passarella, C. Zilio, N. Martinet
, Med. Chem. Commun.
, 2016
, 7
, 1245
- Synthesis, activity and metabolic stability of non-ribose containing inhibitors of histone methyltransferase DOT1L. Lisheng Deng, Li Zhang, Yuan Yao, Cong Wang, Michele S. Redell, Shuo Dong, Yongcheng Song
, Med. Chem. Commun.
, 2013
, 4
, 822
- Small-molecular modulators of cancer-associated epigenetic mechanisms. Yukihiro Itoh, Takayoshi Suzuki, Naoki Miyata
, Mol. BioSyst.
, 2013
, 9
, 873
- Lysine methyltransferase inhibitors: where we are now. Alessandra Feoli, Monica Viviano, Alessandra Cipriano, Ciro Milite, Sabrina Castellano, Gianluca Sbardella
, RSC Chem. Biol.
, 2022
, 3
, 359